Home Use of Mechanical Insufflation/Exsufflation in Adult Patients in Western Switzerland.
Details
Download: 36724753.pdf (284.22 [Ko])
State: Public
Version: Final published version
License: CC BY-NC 4.0
State: Public
Version: Final published version
License: CC BY-NC 4.0
Serval ID
serval:BIB_FB9A31033425
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
Home Use of Mechanical Insufflation/Exsufflation in Adult Patients in Western Switzerland.
Journal
Respiration; international review of thoracic diseases
ISSN
1423-0356 (Electronic)
ISSN-L
0025-7931
Publication state
Published
Issued date
2023
Peer-reviewed
Oui
Volume
102
Number
5
Pages
341-350
Language
english
Notes
Publication types: Observational Study ; Journal Article
Publication Status: ppublish
Publication Status: ppublish
Abstract
Mechanical insufflation/exsufflation (MI-E) devices are often prescribed to patients with inefficient cough and recurrent infections, but their use in the home setting is not well characterized.
The objective of this study was to report a real-life experience and identify factors that are associated with home MI-E use in adult patients.
This is a cross-sectional observational study of adult subjects with neurological disease using MI-E at home for more than 3 months.
A total of 43 patients were included. Median age (interquartile range) was 48 (31-64) years. The most common diagnosis was muscular dystrophy (n = 15), followed by multiple sclerosis (n = 7) and amyotrophic lateral sclerosis (n = 7). 24 subjects (56%) reported using the MI-E at least once weekly. Based on device data downloads, the median objective use was 23% of days analysed (approximately 2 times per week). The vast majority (94%) of all participants reported using the device at least daily during an infectious episode, while 62% reported having used the device in emergency situations such as bronchoaspiration. Reported use correlated well with objective use (r = 0.82). Most subjects reported an improvement in their respiratory health (64%) and were satisfied with the device (78%). Higher reported and objective use were associated with increased symptoms (p = 0.001) and higher satisfaction with the device (p = 0.008). We found no association between frequency of use and baseline cough peak flow (CPF), bulbar impairment, non-invasive ventilation use, living environment, or supervised administration.
Regular home MI-E use was associated with greater symptom burden and overall satisfaction with the device and was not influenced by baseline CPF. Patients without substantial bronchorrhea might not use the MI-E regularly but might still need to use the device at home during acute events. Therefore, familiarity with the MI-E via appropriate and repeated practical training is crucial.
The objective of this study was to report a real-life experience and identify factors that are associated with home MI-E use in adult patients.
This is a cross-sectional observational study of adult subjects with neurological disease using MI-E at home for more than 3 months.
A total of 43 patients were included. Median age (interquartile range) was 48 (31-64) years. The most common diagnosis was muscular dystrophy (n = 15), followed by multiple sclerosis (n = 7) and amyotrophic lateral sclerosis (n = 7). 24 subjects (56%) reported using the MI-E at least once weekly. Based on device data downloads, the median objective use was 23% of days analysed (approximately 2 times per week). The vast majority (94%) of all participants reported using the device at least daily during an infectious episode, while 62% reported having used the device in emergency situations such as bronchoaspiration. Reported use correlated well with objective use (r = 0.82). Most subjects reported an improvement in their respiratory health (64%) and were satisfied with the device (78%). Higher reported and objective use were associated with increased symptoms (p = 0.001) and higher satisfaction with the device (p = 0.008). We found no association between frequency of use and baseline cough peak flow (CPF), bulbar impairment, non-invasive ventilation use, living environment, or supervised administration.
Regular home MI-E use was associated with greater symptom burden and overall satisfaction with the device and was not influenced by baseline CPF. Patients without substantial bronchorrhea might not use the MI-E regularly but might still need to use the device at home during acute events. Therefore, familiarity with the MI-E via appropriate and repeated practical training is crucial.
Keywords
Humans, Adult, Middle Aged, Cough, Insufflation, Cross-Sectional Studies, Switzerland, Respiration, Artificial, Cough assistance, Mechanical insufflation-exsufflation, Neurological disease, Neuromuscular disease
Pubmed
Web of science
Open Access
Yes
Create date
13/02/2023 17:37
Last modification date
16/11/2023 7:24